Luye Pharma Group Ltd.
Clinical trials sponsored by Luye Pharma Group Ltd., explained in plain language.
-
New hope for hard-to-treat colon cancer: experimental drug combo enters human trials
Disease control Not yet recruitingThis study tests an experimental drug (LPM6690176) combined with standard chemotherapy and bevacizumab in people with metastatic colorectal cancer that has a RAS mutation. The goal is to find a safe dose and see if the combination works better than standard treatment alone. About…
Phase: PHASE1, PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New schizophrenia pill aims to ease psychotic episodes
Symptom relief Not yet recruitingThis study tests an experimental drug called LY03020 in 160 adults with schizophrenia who are having acute psychotic symptoms. Participants will receive either the drug or a placebo for a fixed period, and researchers will measure changes in symptom severity using a standard rati…
Phase: PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Symptom relief
Last updated May 17, 2026 08:14 UTC
-
Huntington drug tracking study launches in healthy men
Knowledge-focused Not yet recruitingThis early-stage study looks at how a radioactive form of the experimental Huntington disease drug LPM3770164 is processed and removed from the body. Eight healthy Chinese men will take a single dose, and researchers will measure the drug and its breakdown products in blood, urin…
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 08:01 UTC